Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenstr?m's macroglobulinemia.
Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenstr?m's macroglobulinemia. Ann Hematol. 2016 Jan; 95(2):347-8.